View More View Less
  • 1 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged Dóm tér 10, H-6720 Szeged, Hungary
  • | 2 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged Dóm tér 10, H-6720 Szeged, Hungary
  • | 3 2nd Department of Medicine and Cardiology Center, Faculty of Medicine, University of Szeged Szeged, Hungary
  • | 4 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged Dóm tér 10, H-6720 Szeged, Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Myelodysplastic syndrome (MDS) is a family of clonal disorders characterized by dyshematopoiesis and susceptibility to acute myelogenous leukemia. Tumor necrosis factor-a (TNF-a) and transforming growth factor-b (TGF-b) are cytokines that play key roles in the pathogenesis of MDS. There have been several reports on the presence of genetic polymorphisms in the DNA sequence encoding the leader sequence of the TGF-b 1 protein, and in the -308 promoter region of TNF-a. The association between TNF-a and TGF-b 1 gene polymorphism and the susceptibility to MDS and the progression of the disease was investigated. As compared with healthy control subjects (n = 74), patients with MDS (n = 55) showed no significant deviations in genotype or allele frequencies of TNF-a. Similarly, there were no differences in the distribution of TNF-a genotypes between the MDS patients with only anemia (mild group) and those with bi- or pancytopenia (severe group). On the other hand the TT homozygosity at codon 10 in exon 1 of TGF-b 1 gene was associated with a severe degree of cytopenia [95% CI OR = 4.889, p = 0.0071]. These findings suggest that the investigated genetic polymorphisms do not predispose to the development of MDS, but that TGF-b 1 gene polymorphism may affect the disease progression.

  • Awad, M. R., El-Gamel, A., Hasleton, P., Turner, D. M., Sinnott, P. J., Hutchinson, I. V.: Genotypic variation in the transforming growth factor-betal gene: association with transforming growth factor-betal production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66, 1014-1020 (1998).

    'Genotypic variation in the transforming growth factor-betal gene: association with transforming growth factor-betal production, fibrotic lung disease, and graft fibrosis after lung transplantation. ' () 66 Transplantation : 1014 -1020.

    • Search Google Scholar
  • Arkwright, P. D., Laurie, S., Super, M., Pravica, V., Schwarz, M. J., Webb, A. K., Hutchinson, I. V.: TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55, 459-462 (2000).

    'TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. ' () 55 Thorax : 459 -462.

    • Search Google Scholar
  • Hinke, V., Seck, T., Clanget, C., Scheidt-Nave, C., Ziegler, R., Pfeilschifter, J.: Association of transforming growth factor-beta 1 (TGF-betal) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta 1 in a population-based sample of postmenopausal German women. Calcified Tissue Intern 69, 315-320 (2001).

    'Association of transforming growth factor-beta 1 (TGF-betal) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta 1 in a population-based sample of postmenopausal German women. ' () 69 Calcified Tissue Intern : 315 -320.

    • Search Google Scholar
  • Tang, G. J., Huang, S. L., Yien, H. W., Chen, W. S., Chi, C. W., Wu, C. W., Lui, W. Y., Chiu, J. H., Lee, T. Y.: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 28, 2733-2736 (2000).

    'Tumor necrosis factor gene polymorphism and septic shock in surgical infection. ' () 28 Crit Care Med : 2733 -2736.

    • Search Google Scholar
  • Holweg, C. T., Baan, C. C., Niesters, H. G., Vantrimpont, P. J., Mulder, P. G., Maat, A. P., Weimar, W., Balk, A. H.: TGF-beta 1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 20, 979-984 (2001).

    'TGF-beta 1 gene polymorphisms in patients with end-stage heart failure. ' () 20 J Heart Lung Transplant : 979 -984.

    • Search Google Scholar
  • Warle, M. C., Farhan, A., Metselaar, H. J., Hop, W. C., Perrey, C., Zondervan, P. E., Kap, M., de Rave, S., Kwekkeboom, J., Ijzermans, J. N., Tilanus, H. W., Pravica, V., Hutchinson, I. V., Bouma, G. J.: Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl 8, 603-611 (2002).

    'Cytokine gene polymorphisms and acute human liver graft rejection. ' () 8 Liver Transpl : 603 -611.

    • Search Google Scholar
  • Xaubet, A., Marin-Arguedas, A., Lario, S., Ancochea, J., Morell, F., Ruiz-Manzano, J., Rodriguez-Becerra, E., Rodriguez-Arias, J. M., Inigo, P., Sanz, S., Campistol, J., M., Mullol, J., Picado, C.: Transforming growth factor-beta 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168, 431-435 (2003).

    'Transforming growth factor-beta 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. ' () 168 Am J Respir Crit Care Med : 431 -435.

    • Search Google Scholar
  • Clancy, R. M., Backer, C. B., Yin, X., Kapur, R. P., Molad, Y., Buyon, J. P.: Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 171, 3253-3261 (2003).

    'Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. ' () 171 J Immunol : 3253 -3261.

    • Search Google Scholar
  • Rosenfeld, C., List, A.: A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 14, 2-8 (2000).

    'A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. ' () 14 Leukemia : 2 -8.

    • Search Google Scholar
  • Perrey, C., Turner, S. J., Pravica, V., Howell, W. M., Hutchinson, I. V.: ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transplant Immunology 7, 127-128 (1999).

    'ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. ' () 7 Transplant Immunology : 127 -128.

    • Search Google Scholar
  • McGuire, W., Knight, J. C., Hill, A. V., Allsopp, C. E., Greenwood, B. M., Kwiatkowski, D.: Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Inf Dis 179, 287-290 (1999).

    'Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. ' () 179 J Inf Dis : 287 -290.

    • Search Google Scholar
  • Roodman, G. D., Bird, A., Hutzler, D., Montgomery, W.: Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Haematol 15, 928-935 (1987).

    'Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. ' () 15 Exp Haematol : 928 -935.

    • Search Google Scholar
  • Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A., Deeg, H. J.: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103, 176-188 (1998)).

    'A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. ' () 103 Br J Haematol : 176 -188.

    • Search Google Scholar
  • Bathgate, A. J., Pravica, V., Perrey, C., Therapondos, G., Plevris, J. N., Hayes, P. C., Hutchinson, I. V.: The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. Transplantation 69, 1514-1517 (2000).

    'The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. ' () 69 Transplantation : 1514 -1517.

    • Search Google Scholar
  • Nadel, S., Newport, M. J., Booy, R., Levin, M.: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174, 878-880 (1996).

    'Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. ' () 174 J Infect Dis : 878 -880.

    • Search Google Scholar
  • Stoll, C., Mengsteab, S., Stoll, D., Riediger, D., Gressner, A. M., Weiskirchen, R.: Analysis of polymorphic TGFBI codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. BMC Medical Genetics 5, 15 (2004)).

    'Analysis of polymorphic TGFBI codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. ' () 5 BMC Medical Genetics : 15.

    • Search Google Scholar
  • Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., Yamada, Y.: Association of a T29C polymorphism of the transforming growth factor-betal gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101, 2783-2787 (2000).

    'Association of a T29C polymorphism of the transforming growth factor-betal gene with genetic susceptibility to myocardial infarction in Japanese. ' () 101 Circulation : 2783 -2787.

    • Search Google Scholar
  • Turner, D., Grant, S. C., Yonan, N., Sheldon, S., Dyer, P. A., Sinnott, P. J., Hutchinson, I. V.: Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779 (1997).

    'Cytokine gene polymorphism and heart transplant rejection. ' () 64 Transplantation : 776 -779.

    • Search Google Scholar
  • Azzawi, M., Hasleton, P. S., Turner, D. M., Yonan, N., Deiraniya, A. K., Sinnott, P. J., Hutchinson, I. V.: Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol 62, 140-142 (2001).

    'Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. ' () 62 Hum Immunol : 140 -142.

    • Search Google Scholar
  • Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A., Deeg, H. J.: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103, 176-188 (1998).

    'A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. ' () 103 Br J Haematol : 176 -188.

    • Search Google Scholar
  • Raza, A., Gezer, S., Mundle, S., Gao, X. Z., Alvi, S., Borok, R., Rifkin, S., Ifikhar, A., Shetty, V., Parcharidou, A.: Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86, 268-276 (1995).

    'Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. ' () 86 Blood : 268 -276.

    • Search Google Scholar
  • Moldoveanu, E., Moicean, A., Vidulescu, C., Marta, D., Colita, A.: Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokines. J Cell Mol Med 7, 313-321 (2003).

    'Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokines. ' () 7 J Cell Mol Med : 313 -321.

    • Search Google Scholar
  • Kiss, C., Benko, I., Kovacs, P.: Leukemic cells and the cytokine patchwork. Pediatr Blood Cancer 42, 113-121 (2004).

    'Leukemic cells and the cytokine patchwork. ' () 42 Pediatr Blood Cancer : 113 -121.

  • Molnar, L., Berki, T., Hussain, A., Nemeth, P., Losonczy, H.: Detection of TNFα expression in the bone marrow and determination of TNFa production of peripheral blood mononuclear cells in myelodysplastic syndrome. Pathol Oncol Res 6, 18-23 (2000).

    'Detection of TNFα expression in the bone marrow and determination of TNFa production of peripheral blood mononuclear cells in myelodysplastic syndrome. ' () 6 Pathol Oncol Res : 18 -23.

    • Search Google Scholar
  • Blobe, G. C., Schiemann, W. P., Lodish, H. F.: Role of transforming growth factor beta in human disease. N Engl J Med 342, 1350-1358 (2000).

    'Role of transforming growth factor beta in human disease. ' () 342 N Engl J Med : 1350 -1358.

    • Search Google Scholar
  • Bruno, E., Horrigan, S. K., Van Den Berg, D., Rozler, E., Fitting, P. R., Moss, S. T., Westbrook, C., Hoffman, R.: The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 91, 1917-1923 (1998).

    'The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. ' () 91 Blood : 1917 -1923.

    • Search Google Scholar
  • Allampallam, K., Shetty, V., Mundle, S., Dutt, D., Kravitz, H., Reddy, P. L., Alvi, S., Galili, N., Saberwal, G. S., Anthwal, S., Shaikh, M. W., York, A., Raza, A.: Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. Int J Hematol 75, 289-297 (2002).

    'Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. ' () 75 Int J Hematol : 289 -297.

    • Search Google Scholar
  • Maciejewski, J. P., Risitano, A. M., Sloand, E. M., Wisch, L., Geller, N., Barrett, J. A., Young, N. S., Ristiano, A. M.: A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. Br J Haematol 117, 119-126 (2002).

    'A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. ' () 117 Br J Haematol : 119 -126.

    • Search Google Scholar
  • Greenberg, P.: Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. Ann Rheum Dis 60 Suppl 3), iii 41-42 (2001).

    'Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. ' () 60 Ann Rheum Dis : iii -42.

    • Search Google Scholar
  • Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., Duff, G. W.: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94, 3195-3199 (1997).

    'Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. ' () 94 Proc Natl Acad Sci USA : 3195 -3199.

    • Search Google Scholar
  • Wood, N. A., Thomson, S. C., Smith, R. M., Bidwell, J. L.: Identification of human TGF-betal signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 234, 117-122 (2000).

    'Identification of human TGF-betal signal (leader) sequence polymorphisms by PCR-RFLP. ' () 234 J Immunol Methods : 117 -122.

    • Search Google Scholar
  • Bouma, G., Crusius, J. B., Oudkerk Pool, M., Kolkman, J. J., von Blomberg, B. M., Kostense, P. J., Giphart, M. J., Schreuder, G. M., Meuwissen, S. G., Pena, A. S.: Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43, 456-463 (1996).

    'Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. ' () 43 Scand J Immunol : 456 -463.

    • Search Google Scholar
  • Hellström-Lindberg, E., Willman, C., Barrett, A. J., Saunthararajah, Y.: Achievements in understanding and treatment of myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 110-132 (2000).

  • Greenberg, P. L., Young, N. S., Gattermann, N.: Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 136-161 (2002).

  • Hofmann, W. K., Seipelt, G., Ottmann, O. G., Kalina, U., Koschmieder, S., Brucher, J., Frickhofen, N., Klausmann, M., Mitrou, P. S., Hoelzer, D.: Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. Ann Hematol 79, 255-258 (2000).

    'Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. ' () 79 Ann Hematol : 255 -258.

    • Search Google Scholar
  • Wilson, A. G., di Giovine, F. S., Blakemore, A. I., Duff, G. W.: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1, 353 (1992).

    'Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. ' () 1 Hum Mol Genet : 353.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 1 0 0
May 2021 0 0 0
Jun 2021 1 0 0
Jul 2021 3 0 0
Aug 2021 6 0 0
Sep 2021 3 0 0
Oct 2021 0 0 0